Operating Expenses: The sum of all operating expenses for the given industry.
Immunovant, Inc. (IMVT) Operating Expenses data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-106.45M |
|
-- |
|
-- |
|
|
Operating Expenses |
-- |
$-113.83M |
|
-- |
|
$-105.86M |
|
$-105.86M |
|
$-106.45M |
|
$-106.45M |
|
$-106.45M |
|
$-106.45M |
|
$-113.83M |
|
$-113.72M |
|
151.57M |
|
151.57M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$776.22M |
|
-- |
|
-- |
|
-- |
|
$68.78M |
|
$707.45M |
|
$707.45M |
|
$707.45M |
|
170.11M |
|
| Cash Flow Statement Financials | |
$-375.87M |
|
$-0.76M |
|
$454.49M |
|
$635.37M |
|
$713.97M |
|
$78.61M |
|
$49.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-376.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.05% |
|
-15.05% |
|
-13.71% |
|
-15.05% |
|
$4.16 |
|
$-2.48 |
|
$-2.48 |
|